Galapagos | GLPG - Cash And Equivalent

Stock Price
29.06
Daily Change
-0.10 -0.34%
Monthly
6.45%
Yearly
32.94%
Q1 Forecast
27.75

Galapagos reported EUR64.46M in Cash and Equivalent for its fiscal quarter ending in September of 2025.





Cash And Equivalent Change Date
argenx SE USD 4.3B 2.21B Sep/2025
AstraZeneca USD 8.14B 1.08B Sep/2025
Biogen USD 3.86B 1.1B Sep/2025
Genmab DKK 1.3B 323M Jun/2025
Gilead Sciences USD 5.14B 2.78B Jun/2025
GlaxoSmithKline GBP 3.3B 303M Sep/2025
GRIFOLS EUR 558.69M 194.13M Jun/2025
Hikma Pharmaceutical USD 236M 48M Jun/2025
Incyte USD 2.93B 508.08M Sep/2025
Merck EUR 1.17B 161M Jun/2025
Neurocrine Biosciences USD 340.2M 76.2M Sep/2025
Novartis USD 9.56B 2.9B Sep/2025
Roche Holding CHF 7.55B 579M Jun/2025
Sanofi EUR 7.66B 1.25B Dec/2025
UCB EUR 1.57B 1.14B Dec/2024
Vertex Pharmaceuticals USD 6.29B 95.8M Sep/2025